Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman is battling rumors surrounding superintelligence and AGI (artificial general intelligence). Is ChatGPT ...
Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he ...
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...